Experiment: 6L95

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D TROSY-HSQC	0.6 mM [U-98% 15N;U-98% 13C;U-98% 2H] human bax helix9, 0.1 % DPC, 25 mM HEPES, 150 mM sodium chloride	90% H2O/10% D2O	150 mM	7.5	1 atm	298	Bruker AVANCE 600
2	TROSY-HNCA	0.6 mM [U-98% 15N;U-98% 13C;U-98% 2H] human bax helix9, 0.1 % DPC, 25 mM HEPES, 150 mM sodium chloride	90% H2O/10% D2O	150 mM	7.5	1 atm	298	Bruker AVANCE 600
3	TROSY-HNCOCA	0.6 mM [U-98% 15N;U-98% 13C;U-98% 2H] human bax helix9, 0.1 % DPC, 25 mM HEPES, 150 mM sodium chloride	90% H2O/10% D2O	150 mM	7.5	1 atm	298	Bruker AVANCE 600
4	TROSY-HNCO	0.6 mM [U-98% 15N;U-98% 13C;U-98% 2H] human bax helix9, 0.1 % DPC, 25 mM HEPES, 150 mM sodium chloride	90% H2O/10% D2O	150 mM	7.5	1 atm	298	Bruker AVANCE 600
5	TROSY-HNCACO	0.6 mM [U-98% 15N;U-98% 13C;U-98% 2H] human bax helix9, 0.1 % DPC, 25 mM HEPES, 150 mM sodium chloride	90% H2O/10% D2O	150 mM	7.5	1 atm	298	Bruker AVANCE 600
6	TROSY-HNCACB	0.6 mM [U-98% 15N;U-98% 13C;U-98% 2H] human bax helix9, 0.1 % DPC, 25 mM HEPES, 150 mM sodium chloride	90% H2O/10% D2O	150 mM	7.5	1 atm	298	Bruker AVANCE 600
7	3D 15N NOE-TROSY-HSQC	0.6 mM [U-98% 15N;U-98% 13C;U-98% 2H] human bax helix9, 0.1 % DPC, 25 mM HEPES, 150 mM sodium chloride	90% H2O/10% D2O	150 mM	7.5	1 atm	298	Bruker AVANCE 600
8	3D 15N NOE-TROSY-HSQC	0.6 mM [U-98% 15N;U-98% 13C] human bax helix9, 0.1 % [U-2H] DPC, 25 mM HEPES, 150 mM sodium chloride	90% H2O/10% D2O	150 mM	7.5	1 atm	298	Bruker AVANCE 900
9	3D 13C NOE-HSQC	0.6 mM [U-98% 15N;U-98% 13C] human bax helix9, 0.1 % [U-2H] DPC, 25 mM HEPES, 150 mM sodium chloride	90% H2O/10% D2O	150 mM	7.5	1 atm	298	Bruker AVANCE 900
10	2D 1H-13C HSQC	0.6 mM [U-98% 15N;U-98% 13C] human bax helix9, 0.1 % [U-2H] DPC, 25 mM HEPES, 150 mM sodium chloride	90% H2O/10% D2O	150 mM	7.5	1 atm	298	Bruker AVANCE 900
11	3D 15N NOE-TROSY-HSQC	0.3 mM [U-98% 15N;U-2H] human bax helix9, 0.1 % [U-2H] DPC, 25 mM HEPES, 150 mM sodium chloride	90% H2O/10% D2O	150 mM	7.5	1 atm	298	Bruker AVANCE 900
13	2D TROSY-HSQC	0.3 mM [U-98% 15N;U-2H] human bax helix9, 0.1 % [U-2H] DPC, 25 mM HEPES, 150 mM sodium chloride	90% H2O/10% D2O	150 mM	7.5	1 atm	298	Bruker AVANCE 900
12	2D 1H-13C HSQC	0.4 mM [U-98% 15N;U-15% 13C] human bax helix9, 0.1 % DPC, 25 mM HEPES, 150 mM sodium chloride	90% H2O/10% D2O	150 mM	7.5	1 atm	298	A DD2 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Bruker	AVANCE	900
3	A	DD2	800

NMR Refinement
Method	Details	Software
simulated annealing		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	15
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	structure calculation	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore
3	chemical shift assignment	XEASY		Bartels et al.
4	data analysis	TALOS		Cornilescu, Delaglio and Bax
5	peak picking	CcpNmr Analysis		CCPN
6	collection	TopSpin		Bruker Biospin
7	peak picking	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore
8	refinement	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.